Skip to main content
Albert Bourla

Albert Bourla

CEO of PfizerWikipedia

Search complete. 56 mentions across 38 episodes found for "Albert Bourla".

Nov 21, 2026

speaker_3SOUNDBITE_SPEAKER
5:34
Senator, I'd be happy to take that question on notice and come back to the committee with what information we're able to provide.
Matthew CanavanSOUNDBITE_SPEAKER
5:40
So by June in 2021, in June, on the 8th of June, the Pfizer CEO, Mr Albert Burla, he tweeted, and I quote, that the vaccine was a critical tool to help stop transmission.
Matthew CanavanSOUNDBITE_SPEAKER
5:55
Was there any evidence? What evidence did Mr Burla have by that stage, by June?
speaker_0ADVERTISER
6:00
This episode is brought to you by Indeed.
Damian GardeHOST
6:07
And there's no reason to believe that it would slow down.
Damian GardeHOST
6:10
Just this week, Albert Bourla, the CEO of Pfizer, was presenting at the Jefferies Conference in London.
Damian GardeHOST
6:15
And he said, looking out to 2030 and beyond, I don't believe my competitors will be AstraZeneca, Eli Lilly, other major pharma firms.
Damian GardeHOST
6:22
I believe they will all be Chinese, which...
John LaMattinaGUEST
23:41
Well, that sort of cooled companies' excitement over going into these things.
John LaMattinaGUEST
23:46
And so particularly bigger companies, I've been out of Pfizer for 15 years, so I don't exactly have a hotline to the current CEO, Albert Bourla.
John LaMattinaGUEST
23:55
But I know Albert a little bit, and I happened to run into him a couple of years ago at a meeting.
John LaMattinaGUEST
24:00
And it was just after Pfizer that had a research unit and discovered a research unit in Cambridge in rare diseases, cut it.

16 MINS LATER

John LaMattinaGUEST
40:33
Orphan Annie isn't singing, John.
John LaMattinaGUEST
40:35
Orphan Annie and orphan drugs aren't singing.
John LaMattinaGUEST
40:38
But I will say the CEOs of all of these companies, and not just the big ones, but smaller ones, try to build bridges down in D.C., work together with whatever administration is down there, aren't dismissive of people, and try and get people as educated as much possible along the way.
John LaMattinaGUEST
40:55
I mean, there are so many issues, more issues we are facing right now in this country than drug pricing that I think we're not on the top level of things that I think need to be fixed, with the exception of drugs.
Steven HatfillGUEST
70:36
They couldn't figure out what to do with me.
Steven HatfillGUEST
70:39
And I turned on the TV and there's the president shaking hands with Albert Bourla.
Steven HatfillGUEST
70:47
And there's Kennedy's in the background.
Steven HatfillGUEST
70:52
And they're celebrating the fact that Pfizer is going to put in a $70 billion pharmaceutical production effort on U.S. soil.
Peachy KeenanGUEST
31:35
And so I never knew any of this, but in the course of researching this book, I learned just so many incredible facts like that.
Peachy KeenanGUEST
31:42
The head of Pfizer, Albert Bourla, the one who, you know, got us all the Pfizer vaccines.
Peachy KeenanGUEST
31:48
He's not a doctor either.
Peachy KeenanGUEST
31:49
If you felt like a lab rat during COVID, maybe it's because he's actually a veterinarian.
Alix MayerHOST
0:11
Today, I bring back Todd Callender and whistleblower John White with more information on the Paxlovid scandal.
Alix MayerHOST
0:18
I think most of us have given up on seeing justice for Anthony Fauci and Albert Bourla, but this episode is going to show you that justice is more than likely back on the table.
Alix MayerHOST
0:29
We're going to get into the recently discovered incriminating correspondence between Albert Bourla and Anthony Fauci, and also evidence that there may have been money laundering, believe it or not.
Alix MayerHOST
0:40
Join us in helping make these criminals finally accountable.
Alix MayerHOST
0:43
So don't forget to like, subscribe, leave a comment, and please, please, please, with this episode especially, share it with anybody you think would benefit from this information.

10 MINS LATER

Alix MayerHOST
11:14
Zero.
John WhiteGUEST
11:14
Zero.
Alix MayerHOST
11:15
And the correspondence between Albert Bourla and Anthony Fauci said it was 89% effective to get this on the market and funnel $12 billion to Pfizer, and it was actually a sugar pill of 0% effective.
Shannon JoyHOST
5:35
We went to Netherlands about two weeks ago.
Shannon JoyHOST
5:38
I joined Sasha Latapova as she testified against Bill Gates for his crimes against humanity in a civil case that seeks to hold not only Bill Gates, but also Dutch officials, Albert Burla, the CEO of Pfizer, and other Dutch officials for the injuries that were caused by the COVID-19 vaccines and the fraud that was committed regarding to the COVID-19 vaccines.
Shannon JoyHOST
6:05
It was an amazing event.
Shannon JoyHOST
6:08
Sasha did a great job.
Susan StandfieldGUEST
55:27
So it's not going to be easy because there's still people kicking around.
Susan StandfieldGUEST
55:31
who are involved with these crimes like Gates and Bourla are in the Netherlands court.
Susan StandfieldGUEST
55:36
My friend's covering that case.
Susan StandfieldGUEST
55:38
If you want to interview her, they're, they're pursuing a criminal case against Albert Bourla and Bill Gates right now.
Susan StandfieldGUEST
55:44
And there's still a risk, I think of people like me or you or whoever's blowing the whistle, but it's getting less and less every day.
Susan StandfieldGUEST
55:51
And when the time comes, I think that I will be able to make the movie.
Dan SenorHOST
2:01
It will be two weeks after Israel's election and one week after our midterms here in the U.S. And of course, all of this against the backdrop of anticipated escalation in tensions with Iran.
Dan SenorHOST
2:13
The summit is a full-day event focused on the future of the U.S.-Israel relationship with speakers including former Mossad Director Dari Barnea, Pfizer CEO Albert Bourla, and Ambassador Yehuda Kaplan.
Dan SenorHOST
2:25
who is U.S. Special Envoy to Monitor and Combat Antisemitism.
Dan SenorHOST
2:29
Dr. Miriam Adelson will also be in the audience and on stage.
Ian HaydockHOST
10:00
But investors are already bracing for a challenging two years ahead, and the big test for the company will be if it can hit its return-to-growth goal of high single-digit growth starting after 2028, Jessica Merrill writes.
Ian HaydockHOST
10:14
CEO Albert Bourla and newly minted chief financial officer Cécile Gauguin were pressed by analysts during the company's Q3 sales and earnings call about how Pfizer will return to growth after facing big losses of exclusivity for Ibrans and Xtandi in 2027 and Eliquis in 2028, drugs that make up billions in revenue.
Ian HaydockHOST
10:37
Analysts have a more bearish outlook for Pfizer's long-term trajectory, targeting a slow return to growth in 2030.
Ian HaydockHOST
10:45
If you look at where that difference is coming from, it's not really coming from one place or one product, Gauguin said, presiding over the quarterly call as CFO for the first time.

28 more episodes mention Albert Bourla.

Create an account to see the whole feed, search across every transcript, and follow the entities you care about.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.